Khin, N A <br/><br/>
Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Aug 2013 
 - 230-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2013.70  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--therapeutic use<br/>Cardiovascular Agents--therapeutic use<br/>Clinical Trials as Topic--legislation & jurisprudence<br/>Drug Approval--organization & administration<br/>Guidelines as Topic<br/>Humans<br/>Internationality<br/>Orphan Drug Production--statistics & numerical data<br/>Pharmacology, Clinical--organization & administration<br/>Research Design<br/>United States<br/>United States Food and Drug Administration--legislation & jurisprudence